CEPI – Dynavax, COVID-19 Material Reservation Agreement Post author:GHIAA Admin Post published:January 28, 2022 Post category: Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 21, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement Post author:GHIAA Admin Post published:November 18, 2021 Post category: Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement
CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement Post author:GHIAA Editor Post published:September 15, 2021 Post category: Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement Post author:GHIAA Editor Post published:July 1, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement
Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
US Department of Defense – Ology Bioservices, COVID-19 Plasmid Procurement Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingUS Department of Defense – Ology Bioservices, COVID-19 Plasmid Procurement Agreement
Gates Foundation – CureVac, Global Access Commitments Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac, Global Access Commitments Agreement